Combined MTOR and autophagy inhibition: Phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma

Reshma Rangwala, Yunyoung C. Chang, Janice Hu, Kenneth M. Algazy, Tracey L. Evans, Leslie A. Fecher, Lynn M. Schuchter, Drew A. Torigian, Jeffrey T. Panosian, Andrea B. Troxel, Kay See Tan, Daniel F. Heitjan, Angela M. DeMichele, David J. Vaughn, Maryann Redlinger, Abass Alavi, Jonathon Kaiser, Laura Pontiggia, Lisa E. Davis, Peter J. O'DwyerRavi K. Amaravadi

Clinical Sciences
Clinical Sciences

Research output: Contribution to journal › Article › peer-review

348 Scopus citations

Sort by
Weight
Alphabetically

Combined MTOR and autophagy inhibition: Phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma

Fingerprint

Medicine & Life Sciences